Best Medical Stocks To Research - September 7th

Key Points

• UnitedHealth Group, Eli Lilly, and Johnson & Johnson are identified as the top medical stocks to watch, reflecting high trading volume driven by industry growth and healthcare spending.
• UnitedHealth Group operates a diversified health care model in the U.S., offering a range of services including health benefit plans and care for underserved populations.
• Eli Lilly focuses on developing human pharmaceuticals, offering products for diabetes and obesity, while Johnson & Johnson is involved in innovative medicine and medical technology across various healthcare fields.

UnitedHealth Group, Eli Lilly and Company, and Johnson & Johnson are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare sector, including pharmaceuticals, biotechnology, medical devices, diagnostics and healthcare services. Investors buy these equities to participate in the industry’s growth driven by medical research breakthroughs, an aging population and rising global healthcare spending.‌ Their performance is often sensitive to clinical-trial results, regulatory approvals and changes in health policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Read Our Latest Research Report on JNJ

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.